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What are the indications for urodynamic 
testing in older adults with incontinence?
EVIDENCE-BASED ANSWER Urodynamic testing
is indicated for older adults with incontinence
when the underlying cause remains unclear (Grade
of Recommendation: B, based on multiple well
designed, but inconsistent, randomized controlled
trials [RCTs]). Simple cystometry—specifically,
measuring post void residual and bladder capaci-
ty—is helpful in the evaluation of urinary inconti-
nence when the cause has remained unclear.
It may also offer benefit when surgery is
under consideration, when there is a history
of genitourinary surgery, or when a conserva-
tive therapeutic trial has not had an adequate
response (Grade of Recommendation: C,
based on a small number of RCTs, retrospec-
tive cohort studies and systemic reviews). 
EVIDENCE SUMMARY Current studies
regarding urodynamic testing in older adults
with incontinence are limited by multiple fac-
tors, including inherent gender bias, poor
reproducibility, and small study populations.
Moreover, the lack of a reference standard has con-
tributed to difficulty in assessing outcome meas-
ures. No published study to date has convincingly
supported a role for advanced urodynamic testing
(leak point pressure measurement, pressure flow
studies, electromyelography, etc.) in the evaluation
of routine urinary incontinence. Simple cystometry,
(measuring post-void residuals and determining
bladder capacity), has proved particularly useful in
detecting abnormalities of detrusor compliance
and contractility, especially when the cause of
incontinence is unclear.1, 2
One well designed retrospective cohort study of
950 women found that the positive predictive
value of clinical symptoms in urinary incontinence
alone (74% in the context of a 53% prevalence of
incontinence) was not accurate enough to rely on
for decisions about surgery.3 This study supports
the need for urodynamic evaluation in most
women prior to surgical incontinence treatment.
Another recent small RCT (n=87) found that, of
patients with previous genitourinary surgery or
more severe stress incontinence, about one quarter
were more likely to have their management revised
after urodynamic studies.4 Patients who demon-
strated little or no improvement during the first few
months of conservative treatment also ran a higher
risk of misdiagnosis. Despite these findings, no dif-
ference in treatment outcomes was detected for
women randomized to urodynamic testing. 
Two additional RCTs suggest that, despite the
wide use of urodynamic testing, reproducibility is
limited and may lack sufficient sensitivity and
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specificity to identify underlying pathology.5,6
Specific concerns raised in these studies included
test-retest variation, as well as concerns about pos-
sible interpretation error of urodynamic testing. 
RECOMMENDATIONS FROM OTHERS In its 1996
Clinical Practice Guideline Update, the Agency for
Healthcare Research and Quality (AHRQ) recom-
mended a focused history and targeted examination
(including urinalysis and post-void residual meas-
urement) in order to detect reversible causes of uri-
nary incontinence.1 The guideline stresses that uro-
dynamic testing is invasive and expensive, and it
should be reserved for those situations when the
patient desires such evaluation and the information
gathered would potentially change management.
Although AHRQ considers this guideline too old to
direct current medical practice, we found little
recent evidence to refute these recommendations.
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Indications for urodynamic evaluation in older adults
Unclear diagnosis and inability to develop a reasonable treatment plan based
on basic diagnostic evaluation.
Consideration of surgical intervention, particularly if previous surgery failed or
the patient is a high surgical risk. 
Patient dissatisfaction after an adequate therapeutic trial or desire to pursue
further therapy
Table adapted from Reference 1.
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